GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

FHN · Mar 31, 2022

FIRST HORIZON CORP. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000036966-22-000033Bank
Sequential deposit growth6thOwn-history percentile · N=16
Evidence method

Sequential · gp.financial.deposits

-1.04% · CORE · VALID

Net-income growth38thOwn-history percentile · N=13
Evidence method

Yoy · gp.fundamentals.net_income

-16.31% · CORE · VALID

Interest-expense growth46thOwn-history percentile · N=13
Evidence method

Yoy · gp.financial.interest_expense

-29.55% · CORE · VALID

Cash and equivalents90thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.cash

$1.9B · CORE · VALID

Sequential loan growth50thOwn-history percentile · N=12
Evidence method

Sequential · gp.financial.loans

0.37% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History31 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Decreased
Previous
0.85%
Current
-1.04%
Delta
-1.89%
Earnings Growth Decreased
Previous
18.22%
Current
-16.31%
Delta
-34.53%
Funding Cost Growth Increased
Previous
-30.51%
Current
-29.55%
Delta
0.96%
Liquidity Increased
Previous
$1.8B
Current
$1.9B
Delta
$77.0M
Loan Growth Increased
Previous
-0.94%
Current
0.37%
Delta
1.31%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.